CBD law in France is neither a legal vacuum nor a complete grey area. Since the decree of 30 December 2021 and the Kanavape ruling of the CJEU, the picture has become clearer — even if 2026 brings a sensitive new project on food supplements.
The single threshold: THC below 0.3%
The core rule fits in one sentence. Any hemp-derived product sold in France must contain, in the finished product, less than 0.3% delta-9-tetrahydrocannabinol (THC). The 30 December 2021 decree applies this limit to oils, e-liquids, flowers, resins, cosmetics and food supplements. Above that threshold, the product falls under narcotics law.
CBD (cannabidiol) itself is not classified as a narcotic and has circulated freely within the EU since the Kanavape ruling of 19 November 2020.
Authorised formats
- Sublingual oils — sold as food supplements (with reservations, see below) or cosmetics.
- Raw flowers and resins — allowed since the Conseil d'État ruling of 24 January 2022, which suspended the planned ban.
- CBD e-liquids — under vaping product regulation (TPD), with specific labelling and child-resistant packaging requirements.
- CBD cosmetics — under EU regulation 1223/2009, with the same compliance requirements as any cosmetic.
- Infusions and teas — authorised as food, subject to standard food safety rules.
- Edibles — gummies, chocolates, bars are sold but face the strongest novel food scrutiny.
What is banned
- HHC (hexahydrocannabinol) — banned in France since the ANSM decision of 13 June 2023.
- H4CBD, HHCP, synthetic THCP — banned during 2024 on the same legal basis.
- Therapeutic claims — strictly prohibited on any non-medicinal product.
- Products above 0.3% THC — seized and treated as narcotics.
- Sales to minors — banned by industry self-regulation and customary practice.
The sensitive 2025-2026 file: food supplements
An ANSES and DGCCRF project plans to remove the term "CBD" from food supplement packaging. Stated reason: CBD is not authorised as a novel food under EU regulation 2015/2283. Oils, gummies and capsules sold as supplements would have to obtain EFSA approval or move to another regulatory category. We cover this in detail in a dedicated article.
Driving, work, travel: vigilance zones
Legal does not mean carefree. Three points: residual THC in full-spectrum products may trigger a saliva test; some employers regulate drug screening; outside the EU, Kanavape free circulation no longer applies. Each topic deserves its own attention — see our dedicated articles on driving, workplace and travel.
Who controls compliance?
Three administrations share enforcement: DGCCRF (consumer protection and fraud prevention) handles labelling and shop checks; customs intercept non-compliant imports; ANSM rules on molecule-level bans for semi-synthetics. Coordination is informal but real, especially during sector-wide control campaigns.
The Horus stance
Strict compliance and documented traceability. Every product sold in our Boulogne-sur-Gesse and L'Isle-en-Dodon shops carries a recent certificate of analysis showing THC below 0.3%. No semi-synthetics, no therapeutic claims. Compliance is not a marketing pose: it is the condition for existing in this trade. We refuse to list any product whose paperwork is incomplete, even when the supplier offers a margin advantage — short-term gain rarely survives a DGCCRF inspection.
Further reading: complete decoding of the 30 December 2021 decree.
This article is for informational purposes only. For legal advice, consult a lawyer. CBD is not a medicine.
